ライフサイエンスコーパス: leukocyte adhesion

1 the markers of thrombosis, inflammation, and leukocyte adhesion.

2 onal change in beta2 integrins, facilitating leukocyte adhesion.

3 m by which LA1-activated CD11b/CD18 mediates leukocyte adhesion.

4 and is critical for firm integrin-dependent leukocyte adhesion.

5 t captures CTCs while minimizing nonspecific leukocyte adhesion.

6 LFA-1 also mediates leukocyte adhesion.

7 ptors to assess their relevance for rhythmic leukocyte adhesion.

8 of mobility for the onset of LFA-1 mediated leukocyte adhesion.

9 the inhibition of exocytosis, and suppresses leukocyte adhesion.

10 red to endothelium and subsequently mediated leukocyte adhesion.

11 othelium (P = 0.03) matching the increase in leukocyte adhesion.

12 lammatory signals with those associated with leukocyte adhesion.

13 ed ICAM-1 in endothelial cells (EC) promotes leukocyte adhesion.

14 ation into plaques through platelet-mediated leukocyte adhesion.

15 s an important regulator of CX3CL1-dependent leukocyte adhesion.

16 a preceding activation step to trigger firm leukocyte adhesion.

17 finity triggering mediates chemokine-induced leukocyte adhesion.

18 by integrin-dependent sickle-red blood cell-leukocyte adhesion.

19 microglial activation, and reduced cerebral leukocyte adhesion.

20 tion of HC-HA cable structures and abolishes leukocyte adhesion.

21 ry factor, which inhibits integrin-dependent leukocyte adhesion.

22 ent with metformin decreased the SFA-induced leukocyte adhesion.

23 APN-KO mice also exhibited increased leukocyte adhesion (2.3+/-0.4-fold) and tumor necrosis f

24 e (CX3CL1) and its receptor, CX3CR1, mediate leukocyte adhesion, activation, and trafficking.

25 ional biology: a mechanics-based modeling of leukocyte adhesion (adhesive dynamics) and signal transd

26 and partly prevented increases in VCAM-1 and leukocyte adhesion after treatment with tumour necrosis

27 creased permeability, ICAM-1 expression, and leukocyte adhesion, all of which are features of an infl

28 ated a crucial role for CatG during arterial leukocyte adhesion, an effect not found during venular a

29 uorescence microscopy, we observed excessive leukocyte adhesion and accelerated atherosclerotic plaqu

30 nflammation, vascular lesions with increased leukocyte adhesion and capillary degeneration.

31 In contrast, polymorphonuclear leukocyte adhesion and chemotaxis were normal.

32 gulates many biological processes, including leukocyte adhesion and chemotaxis.

33 clerosis in ApoE(-/-) mice, there is reduced leukocyte adhesion and decreased CD18 expression on Gr1(

34 9)/L platelets, showing reduced signaling in leukocyte adhesion and diapedesis and increased compleme

35 DPA and RvD5n-3 DPA decreased the extent of leukocyte adhesion and emigration following ischemia-rep

36 ntified role for Panx1 channels in promoting leukocyte adhesion and emigration through the venous wal

37 ade body secretion, and in the regulation of leukocyte adhesion and extravasation during inflammation

38 ion in the genetic absence of Coro1A impairs leukocyte adhesion and extravasation in inflamed cremast

39 muscle venules revealed severely compromised leukocyte adhesion and extravasation in MK(-/-) mice com

40 control endothelial cell (EC) permeability, leukocyte adhesion and inflammation are pivotal for athe

41 10-treated mice showed reduced expression of leukocyte adhesion and inflammatory markers, respectivel

42 Functionally, leukocyte adhesion and integrin activation are abrogated

43 show that N-glycosylation of JAM-A regulates leukocyte adhesion and LFA-1 binding.

44 ligands and their ability to intervene with leukocyte adhesion and migration across brain endothelia

45 CX3CR1 is a chemokine receptor involved in leukocyte adhesion and migration and hence a mediator of

46 egment of the microvasculature that supports leukocyte adhesion and migration expands through remodel

47 Constitutive leukocyte adhesion and migration in murine bone marrow (

48 Cs) are well recognized as key regulators in leukocyte adhesion and migration in response to bacteria

49 The finding that Cdk inhibitors can block leukocyte adhesion and migration may expand the clinical

50 t human fetal HSCs employ mechanisms used in leukocyte adhesion and migration to mediate HSC self-ren

51 anscripts encoding for molecules involved in leukocyte adhesion and migration, cytotoxic functions, a

52 nd its ligand CX3CL1 have been implicated in leukocyte adhesion and neuronal protection.

53 dothelial activation manifested as increased leukocyte adhesion and plasma extravasation in response

54 ta2-integrin activation is indispensable for leukocyte adhesion and recruitment to sites of infection

55 Intravital microscopy showed decrease in leukocyte adhesion and rolling after ethanol consumption

56 L-selectin regulates leukocyte adhesion and rolling along the endothelium.

57 new role of fibrinogen in integrin-mediated leukocyte adhesion and suggest that this mechanism may p

58 tify alpha 4 integrin/CD49d as a mediator of leukocyte adhesion and the resultant early signature abn

59 protein I (beta2GPI) induce endothelial cell-leukocyte adhesion and thrombus formation via unknown me

60 ould be used as a therapeutic tool to reduce leukocyte adhesion and thus reduce neuroinflammation.

61 or investigation of lymphatic involvement in leukocyte adhesion and trafficking during the immune res

62 the effects of hemodynamics and cytokines on leukocyte adhesion and trans-endothelial migration (TEM)

63 t human JAM-C to determine its role in human leukocyte adhesion and transendothelial cell migration u

64 ion of endothelial ABPs to the regulation of leukocyte adhesion and transendothelial migration remain

65 e their endothelial cell ligands and support leukocyte adhesion and transendothelial migration.

66 Consequently, leukocyte adhesion and transmigration are significantly

67 synthase and fibrinolytic activity, decrease leukocyte adhesion and transmigration, and enhance resis

68 ound LYVE-1 molecules and thereby facilitate leukocyte adhesion and transmigration.

69 functions including macrophage recognition, leukocyte adhesion and transmigration.

70 beta while an anti-ICAM-1 mAb inhibited both leukocyte adhesion and transmigration.

71 F-induced proliferation and thrombin-induced leukocyte adhesion and triggers a STAT3-dependent increa

72 dase is positively correlated with increased leukocyte adhesion and vascular leakage in diabetes and

73 s and reduced significantly diabetes-induced leukocyte adhesion and vascular leakage.

74 and smooth muscle cell apoptosis as well as leukocytes adhesion and proliferation.

75 Cell polarization is a key step for leukocytes adhesion and transmigration during leukocytes

76 is, cell growth and apoptosis, angiogenesis, leukocyte adhesion, and cytokine activation and inhibiti

77 in atherosclerotic plaques, blocks arterial leukocyte adhesion, and inhibits atherosclerosis and inf

78 hamber protein concentration, retinal vessel leukocyte adhesion, and protein leakage were measured 24

79 at plays a role in tight junction formation, leukocyte adhesion, and transendothelial migration.

80 cells is essential for platelet aggregation, leukocyte adhesion, and transmigration through endotheli

81 a-AR stimulation can promote both SS RBC and leukocyte adhesion as well as vaso-occlusion, suggesting

82 AnxA1Ac2-26 treatment decreased leukocyte adhesion at 40 min and all L-E interactions at

83 ies in the murine inflamed microcirculation (leukocyte adhesion being the readout) and in skin traffi

84 , the retinas were extracted and assayed for leukocyte adhesion; blood-retinal barrier breakdown; VEG

85 hoG by small interfering RNA does not affect leukocyte adhesion but decreases cup formation and inhib

86 tyrosine phosphatase 1 (Shp1) show increased leukocyte adhesion, but the interpretation of these data

87 of the immunoglobulin superfamily, supports leukocyte adhesion by binding alpha4beta1 integrins and

88 3 cells, suggesting that these miRs regulate leukocyte adhesion by modulating the expression of adhes

89 Understanding of the leukocyte adhesion cascade and interactions of leukocyte

90 Despite expanded definition of the leukocyte adhesion cascade and mechanisms underlying ind

91 These data provide unique insights in the leukocyte adhesion cascade and the potential for time-ba

92 Current in vitro models of the leukocyte adhesion cascade cannot be used for real-time

93 The leukocyte adhesion cascade is important in chronic lymph

94 tion in vivo and add additional steps to the leukocyte adhesion cascade that supports leukocyte traff

95 be used for real-time studies of the entire leukocyte adhesion cascade, including rolling, adhesion,

96 N-glycans contributing to all aspects of the leukocyte adhesion cascade, O-glycans only being importa

97 sses have been identified in the endothelial-leukocyte adhesion cascade.

98 the endothelium commonly referred to as the leukocyte adhesion cascade.

99 llular MRP8/14 as an autocrine player in the leukocyte adhesion cascade.

100 In view of the capacity of FKN to mediate leukocyte adhesion, chemoattraction, and transmigration,

101 This diminished leukocyte adhesion correlated with the magnitude of gran

102 le and a prolongation of chemokine-dependent leukocyte adhesion could be observed.

103 Leukocyte adhesion, crawling, and transmigration are reg

104 s in this disappearance, a dog having canine leukocyte adhesion deficiency (CLAD) or CLAD dogs who ha

105 Canine leukocyte adhesion deficiency (CLAD) represents the cani

106 e use of foamy virus vectors to treat canine leukocyte adhesion deficiency (CLAD).

107 ect in different human cell types, including leukocyte adhesion deficiency (LAD) patient-derived immo

108 umans, mutations in beta(2) integrin lead to leukocyte adhesion deficiency (LAD) syndrome and mutatio

109 activation on neutrophils is the hallmark of leukocyte adhesion deficiency (LAD) syndrome in humans,

110 PURPOSE OF REVIEW: The leukocyte adhesion deficiency (LAD) syndromes are rare g

111 the canine counter-part of the human disease leukocyte adhesion deficiency (LAD).

112 ed IL-17 has also been shown in SLE, RA, and leukocyte adhesion deficiency and may contribute to oral

113 in inherited and acquired disorders, such as leukocyte adhesion deficiency and myelodysplasia.

114 Chronic granulomatous disease and leukocyte adhesion deficiency are the major primary immu

115 ontrasts with the phenotype seen in type III leukocyte adhesion deficiency caused by the absence of k

116 nd identify CF as a new, cell type-selective leukocyte adhesion deficiency disease, providing new ins

117 The protein kindlin 3 is mutated in the leukocyte adhesion deficiency III (LAD-III) disorder, le

118 In the disorder leukocyte adhesion deficiency III (LAD-III), integrins o

119 e severe than those reported for people with leukocyte adhesion deficiency III (LAD-III).

120 de an effective, but less toxic approach for leukocyte adhesion deficiency in children.

121 ivation on leukocytes is the hallmark of the leukocyte adhesion deficiency syndrome in humans, charac

122 f young dogs with the genetic disease canine leukocyte adhesion deficiency that were treated with a n

123 Immune cells from patients with leukocyte adhesion deficiency type 1 (LAD-1) had reduced

124 Previous studies using phagocytes from a leukocyte adhesion deficiency type 1 (LAD-I) patient ide

125 A patient with leukocyte adhesion deficiency type 1 (LAD1) had severe p

126 e the contribution of CD18 on neutrophils to leukocyte adhesion deficiency type I (LAD-I), a complex

127 se), severe congenital neutropenia (SCN) and leukocyte adhesion deficiency type I confer a predisposi

128 lts imply that the immunodeficiency found in leukocyte adhesion deficiency type III patients, in addi

129 accumulation of HSPCs in the circulation of leukocyte adhesion deficiency type III patients, who lac

130 hat is mutated in the rare genetic disorder, leukocyte adhesion deficiency type III, a disorder chara

131 n-3 is mutated in the rare genetic disorder, leukocyte adhesion deficiency type III, which is charact

132 Leukocyte adhesion deficiency type-1 (LAD-1) is an autos

133 enital origin (e.g., congenital neutropenia, leukocyte adhesion deficiency, and Chediak-Higashi syndr

134 cell activity is impaired, but not absent in leukocyte adhesion deficiency, may lead to the developme

135 which die perinatally of severe bleeding and leukocyte adhesion deficiency, mice expressing as little

136 Subjects with leukocyte adhesion deficiency-1 (LAD-I) do not express b

137 A canine model of leukocyte adhesion deficiency-I facilitated development

138 Preimplantation genetic diagnosis of leukocyte adhesion deficiency-I led to the birth of a no

139 adhesion deficiency-I; prenatal diagnosis of leukocyte adhesion deficiency-I; and association of auto

140 e adhesion deficiency-I; transplantation for leukocyte adhesion deficiency-I; prenatal diagnosis of l

141 herapy for chronic granulomatous disease and leukocyte adhesion deficiency-I; transplantation for leu

142 ng kindlin-3, the protein that is mutated in leukocyte adhesion deficiency-III patients.

143 Patients with Glanzmann thrombasthenia or Leukocyte Adhesion Deficiency-III syndrome (LAD-III or L

144 tudying a patient with kindlin-3 deficiency (leukocyte adhesion deficiency-III).

145 nderlie the human immune deficiency known as leukocyte adhesion deficiency-III.

146 matous disease and beta2 integrin defects in leukocyte adhesion deficiency.

147 ll transplant and gene therapy approaches to leukocyte adhesion deficiency.

148 E) abolished the inhibitory effect of gAd on leukocyte adhesion, demonstrating the obligatory role of

149 Leukocyte adhesion during inflammation is initiated by t

150 electin, ICAM-1, and EphB4 and were sites of leukocyte adhesion during lipopolysaccharide-induced acu

151 Superfusion with IS induced strong leukocyte adhesion, enhanced extravasation, and interrup

152 lence at least in part by impeding Fg-driven leukocyte adhesion events.

153 Similarly, leukocyte adhesion, extravasation, and bacterial clearan

154 of temporal patterns of rhodamine-6G-labeled leukocyte adhesion/extravasation, was used.

155 molecules, including interleukin (IL)-6, the leukocyte adhesion factor ICAM1, and chemokines that att

156 ter B lymphocytes from mice with a defect in leukocyte adhesion fail to divide asymmetrically.

157 ctionally important endogenous inhibitors of leukocyte adhesion have not been identified.

158 Intravitreal IL-6 directly induced leukocyte adhesion in both wild-type and IL-6-deficient

159 muscle confirmed the defect of CXCL1-induced leukocyte adhesion in HPK1-deficient mice.

160 rolling on unstimulated veins and increased leukocyte adhesion in inflamed veins.

161 ceded clinical signs of anterior uveitis and leukocyte adhesion in iris vasculature.

162 eceptors in endothelial cells also increased leukocyte adhesion in mesenteric venules and increased t

163 ition of KDM7A and UTX significantly reduces leukocyte adhesion in mice, establishing the biological

164 rteriogenesis, thrombosis, inflammation, and leukocyte adhesion in patients with intermittent claudic

165 rupts capillary fine structure and increases leukocyte adhesion in postcapillary venules.

166 Insulin decreased VCAM-1 expression and leukocyte adhesion in quiescent tumour endothelial cells

167 ]-3-methyl-cyclohexanol), greatly attenuated leukocyte adhesion in surface pial vessels and in deep a

168 n leukocyte rolling and a 5-fold increase in leukocyte adhesion in the microcirculation.

169 Leukocyte adhesion in the microvasculature influences bl

170 d protein content in the aqueous fluid, firm leukocyte adhesion in the retinal vessels, and the numbe

171 rm during inflammatory processes and mediate leukocyte adhesion in the synovial fluids of arthritis p

172 d the mechanistic roles of hyperglycemia and leukocyte adhesion in this process.

173 l Del-1 deficiency increased LFA-1-dependent leukocyte adhesion in vitro and in vivo.

174 ion molecules (ICAMs) in cis, which inhibits leukocyte adhesion in vitro and in vivo.

175 Using a leukocyte adhesion in vitro assay under shear forces mim

176 pproximately 33 mumol) mitigated LPS-induced leukocyte adhesion in WT and AnxA1-null animals without

177 h soluble fibrinogen exerts its influence on leukocyte adhesion indicated that it did not block integ

178 studied endothelial permeability, intravital leukocyte adhesion, involvement of the Akt/WNT/beta-cate

179 Integrin-mediated leukocyte adhesion is central to this process.

180 Leukocyte adhesion is determined by the balance between

181 Leukocyte adhesion is mediated mainly by selectins, cell

182 organization of endothelial ICAM-1 regulates leukocyte adhesion is not well understood.

183 A key parameter influencing leukocyte adhesion is the shear stress acting on the leu

184 Leukocyte adhesion is triggered by the interaction of va

185 platelet dysfunction in addition to impaired leukocyte adhesion, is now known to be due to absence of

186 m from obese mice expressed higher levels of leukocyte adhesion markers and lower levels of cell-cell

187 ignificantly increased the expression of the leukocyte adhesion markers LFA-1 and VLA-4, consistent w

188 Platelet-leukocyte adhesion may contribute to thrombosis and infl

189 Evidence suggests that disrupting leukocyte adhesion may prevent the impairment of renal m

190 macrophage-1 antigen complex, which mediates leukocyte adhesion, migration and phagocytosis as part o

191 and functions in diverse capacities such as leukocyte adhesion, migration, and cell survival on liga

192 dose of natalizumab, an antibody against the leukocyte adhesion molecule alpha4 integrin, in patients

193 ) and increased expression of membrane-bound leukocyte adhesion molecule CD11b, leading to enhanced i

194 this report, we have determined that the EC-leukocyte adhesion molecule E-selectin is a key target f

195 E-selectin, a leukocyte adhesion molecule expressed on endothelium, is

196 irectly suppressed endothelial activation of leukocyte adhesion molecule expression and inflammation.

197 or the synthesis of functional selectin-type leukocyte adhesion molecule ligands.

198 ical surface, where JAM-A played a role as a leukocyte adhesion molecule participating in transendoth

199 Increased leukocyte adhesion molecule VCAM-1 expression and leukoc

200 observed elevated expression of endothelial leukocyte adhesion molecule-1, a human glaucoma marker,

201 but under inflammatory conditions acts as a leukocyte adhesion molecule.

202 ulatory role in cytokine induction of the EC-leukocyte adhesion molecules (ELAM) E-selectin and vascu

203 Therefore, the expression of leukocyte adhesion molecules and secretion of proinflamm

204 The characterization of leukocyte adhesion molecules and their control by proinf

205 eta2 integrins (CD11/CD18) are heterodimeric leukocyte adhesion molecules expressed on hematopoietic

206 TNF-alpha induces leukocyte adhesion molecules on endothelial cells (ECs),

207 t, Rho GTPases affect the expression of some leukocyte adhesion molecules on endothelial cells, such

208 In contrast, the genes for leukocyte adhesion molecules showed a significant upregu

209 esion, and extravasation by up-regulation of leukocyte adhesion molecules such as E-selectin and P-se

210 e-inducible, NF-kappaB-dependent endothelial-leukocyte adhesion molecules that participate in the leu

211 tigated the role of p75 in TNF-alpha-induced leukocyte adhesion molecules using cultured ECs derived

212 ir ability to regulate the expression of key leukocyte adhesion molecules, on both leukocytes and end

213 capillaries enlarged into venules expressing leukocyte adhesion molecules, sprouting angiogenesis and

214 that the phenolic content of RW may modulate leukocyte adhesion molecules, whereas both ethanol and p

215 associated with endothelial upregulation of leukocyte adhesion molecules, which persist even after i

216 Transient mild leukocyte adhesion occurred in mCMV-ND venules at 7 and

217 or IL-6, and their retinas were analyzed for leukocyte adhesion or for the expression and localizatio

218 a(2+)]i in endothelial cells does not affect leukocyte adhesion or locomotion but selectively blocks

219 strains lacking Pra1p were unable to support leukocyte adhesion or migration.

220 No significant leukocyte adhesion or rolling, nor changes in capillary

221 scular permeability, tissue edema, augmented leukocyte adhesion, platelet aggregation, and dysregulat

222 scular complications, the role that rhythmic leukocyte adhesion plays in different vascular beds has

223 w glycocalyx damage or removal will increase leukocyte adhesion potential during inflammation.

224 ndogenous inhibitors, as well as the role of leukocyte adhesion-promoting molecules) has provided new

225 Mechanisms controlling leukocyte adhesion, propulsion and directional migration

226 matory markers, neutrophil chemoattractants, leukocyte adhesion proteins, and matrix metalloproteases

227 coli strains, targets a broad range of human leukocyte adhesion proteins.

228 form to the TNFalpha-induced upregulation of leukocyte adhesion proteins.

229 We report that in addition to supporting leukocyte adhesion, provision of specific substrate to V

230 shear stress responses, and TNFalpha-induced leukocyte adhesion rates characteristic of arterial endo

231 y increases in endothelial expression of the leukocyte adhesion receptor E-selectin and in microvascu

232 xide production, and by direct modulation of leukocyte adhesion receptor expression.

233 CD44, the leukocyte adhesion receptor for hyaluronan, has been con

234 The leukocyte adhesion receptor L-selectin forms bonds with

235 Pases are activated by engagement of several leukocyte adhesion receptors and contribute to both earl

236 The selectin family of leukocyte adhesion receptors is principally recognized f

237 G, interact with ICAM-1 and are recruited to leukocyte adhesion sites.

238 tivity C-reactive protein, osteopontin), and leukocyte adhesion (soluble vascular cell adhesion molec

239 addressed this problem, two key features of leukocyte adhesion, such as cell deformation and rolling

240 n endothelial cells and, in turn, to augment leukocyte adhesion, thus exacerbating S1P-mediated proad

241 chronic inflammatory disease associated with leukocyte adhesion to and extravasation through vascular

242 tation of ICAM and VCAM expression, elevated leukocyte adhesion to and migration across BMVEC monolay

243 Leukocyte adhesion to brain endothelial cells, the blood

244 a inhibition in vivo substantially decreased leukocyte adhesion to brain endothelium under inflammato

245 PolyI:C-induced, HA-mediated leukocyte adhesion to colon SMCs from STAT1-null mice wa

246 AM-1 is best known for its role in mediating leukocyte adhesion to endothelial cells and guiding leuk

247 treated SS RBCs induced activation of murine leukocyte adhesion to endothelium as well.

248 ich SS RBCs act via LW and CD44 to stimulate leukocyte adhesion to endothelium, and suggest that RBC

249 so purified LFA-1, an integrin that mediates leukocyte adhesion to endothelium.

250 expression in renal vascular endothelium and leukocyte adhesion to endothelium.

251 is study investigated the regulation of firm leukocyte adhesion to human brain endothelium by two dif

252 igation rapidly activated integrin-dependent leukocyte adhesion to immobilized ICAM-1 and fibronectin

253 in multiple leukocyte populations, impaired leukocyte adhesion to inflamed vessels, and accumulation

254 Leukocyte adhesion to P-selectin on activated platelets

255 ation of AnxA1(2-50) markedly reduced (>60%) leukocyte adhesion to postcapillary venules in wild type

256 e blockade of NAD(P)H oxidase in turn blocks leukocyte adhesion to retinal vessels during diabetes an

257 tent with these findings, we found increased leukocyte adhesion to sdc-1 knock-out endothelial cells

258 rst description of a mechanism that prevents leukocyte adhesion to the endothelium by a parasite and

259 Furthermore, IL-35 inhibited leukocyte adhesion to the endothelium in the vessels of

260 However, leukocyte adhesion to the fibrin clot can be detrimental

261 It promotes leukocyte adhesion to the liver in vivo and drives lymph

262 dose-dependently inhibited TNF-alpha-induced leukocyte adhesion to the murine cremasteric arterioles

263 ed increases in IL-6 mRNA and protein and in leukocyte adhesion to the retinal vessels.

264 ET-1-treated PbN-infected mice displayed leukocyte adhesion to the vascular endothelia and petech

265 ology of diabetic retinopathy is mediated by leukocyte adhesion to the vascular endothelium of the di

266 Inhibition of leukocyte adhesion to the vascular endothelium represent

267 Leukocyte adhesion to the vascular wall is a critical ea

268 iferation of plaque resident macrophages and leukocyte adhesion to the vascular wall were significant

269 Intriguingly, leukocyte adhesion to the vasculature is significantly i

270 t limits endothelial activation and prevents leukocyte adhesion to the vessel wall.

271 dition of heavy chains to HA cables enhanced leukocyte adhesion to these cables, but it also had seve

272 Finally, HDL inhibited leukocyte adhesion to TNFalpha-stimulated ECs isolated f

273 to nude mice promotes both SS RBC and murine leukocyte adhesion to vascular endothelium in vivo.

274 s (such as VCAM-1 the ligand for VLA-4), and leukocyte adhesion to vascular endothelium.

275 Human polymorphonuclear leukocytes adhesion to endothelial cells during the earl

276 nd hemorrhagic shock did not further amplify leukocytes adhesion to intestinal venules compared with

277 oxemia and hemorrhagic shock did not amplify leukocytes adhesion to the endothelium further than eith

278 Furthermore, hemorrhagic shock triggered leukocytes adhesion to the venular endothelium to the sa

279 Hypoxemia also triggered leukocytes adhesion to the venular endothelium.

280 y for rapid activation of integrin-dependent leukocyte adhesion, triggered by toll-like receptor (TLR

281 the essential role for TXNIP in mediating EC-leukocyte adhesion under d-flow, as well as define a nov

282 c IgG and assembled immune complexes amplify leukocyte adhesion under dynamic conditions.

283 core-1/Galbeta1,3GalNAc glycan may regulate leukocyte adhesion under fluid shear.

284 llular adhesion molecule-1 (ICAM-1) mediates leukocyte adhesion under force.

285 ppressed the LPS-induced increase in retinal leukocyte adhesion; vascular leakage; NF-kappaB, HIF-1al

286 r contributed to activation of NF-kappaB and leukocyte adhesion via the EC induction of intercellular

287 glycosylation, sialyl Lewis-X formation, and leukocyte adhesion via the selectins.

288 Leukocyte adhesion was assayed by concanavalin A labelin

289 Leukocyte adhesion was assessed by labeling adherent leu

290 Platelet and leukocyte adhesion was assessed in cortical venules with

291 Leukocyte adhesion was evaluated by chemotaxis and in vi

292 Unexpectedly, although in arteries leukocyte adhesion was highest in the morning, it peaked

293 ferase FUT9 played an important role because leukocyte adhesion was reduced by 50-60% in FUT9-HL-60,

294 tically upregulated at the onset of hypoxia, leukocyte adhesion was unaffected.

295 Differences in cell adhesion molecules and leukocyte adhesion were ablated when disrupting sympathe

296 expression on retinal neovascularization and leukocyte adhesion were abolished in mice lacking TNF-al

297 Similarly, leukocyte adhesions were significantly lower, with eleva

298 hyaluronan production or hyaluronan-mediated leukocyte adhesion when treated with the viral mimic pol

299 ith SFA or inhibition of autophagy increased leukocyte adhesion, whereas treatment with metformin dec

300 rolling phase resulting in the transition to leukocyte adhesion, which appear to contribute to chemok

301 tion of CatG specifically abrogated arterial leukocyte adhesion without affecting myeloid cell adhesi